Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Medicis Pharmaceutical Corp.
Current Parent CompanyBausch Health
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $35,000,000
Year: 2018
Date: July 18, 2018
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: Medicis, a subsidiary of Valeant Pharmaceuticals, agreed to pay $35 million to direct purchaser plaintiffs to settle allegations relating to its role in an arrangement to delay launching a generic version of the acne medication Solodyn.
Level of Government: federal
Action Type: private litigation
Court: District of Massachusetts
Civil or Criminal Case: civil
Case ID: 1:14-md-02503
Case Name: In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Canada
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Link to PACER Case Docket (must be logged in)(click here)
Link to Archived Court Document subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.